KVUE

3 Undervalued Stocks to Consider Buying Now

by

Dear readers:   With the markets retracing most of their recent drawdown, we’re taking a victory lap as we didn’t panic, nor should have you. We highlighted our wait-and-see approach amidst the worst of the pullback, and we expect the Magnificent 7 (large cap growth and big cap tech) to continue to propel the markets higher, as they have done.   We’ve been busy rolling valuation models as we finetune our assumptions for a great number of companies under coverage. While doing so, we came across three undervalued stocks that are also included in the simulated newsletter portfolios. We think they’re prime for highlight.   The three stocks are UnitedHealth Group (UNH), Nvidia (NVDA) and Alphabet (GOOG). We spend a lot of time on discounted cash-flow valuation, … Read more

We Remain Bullish; Is This 1995 – The Beginning of a Huge Stock Market Run?

by

Image: Large cap growth stocks have trounced the performance of the S&P 500, REITs, and bonds since the beginning of 2023. We expect continued outperformance in this area of the market. By Brian Nelson, CFA We’re now roughly four years past the depths of the COVID-19 meltdown, where equities collapsed in February and March of 2020. As the markets began to recover through 2020, our long-term conviction in equities only grew stronger. We think the biggest risk for long-term investors remains staying out of the market on the basis of what could be considered stretched valuation multiples. As we outlined heavily in the book Value Trap, valuation multiples hardly tell the complete story about a company and often omit key … Read more

Stock Reports on 25 Dividend Kings to Pad Your Dividend Growth Portfolio

by

Image Source: Jason Train By Valuentum Analysts Investors love dividends! After all, research has shown that companies that have paid an ever-increasing dividend for a long time do quite well in the stock market. In this note, you can download the stock reports of 25 Dividend Kings, or stocks that have raised their dividends in each of the past 50 years! Please select the company’s name/symbol below to download the 16-page report. Don’t forget that we also have Dividend Reports for these companies, too!  —– Genuine Parts (GPC) — 67 Years   Parker-Hannifin (PH) — 67 Years   Procter & Gamble (PG) — 67 Years   Emerson Electric (EMR) — 66 Years   3M (MMM) — 65 Years   Coca-Cola … Read more

12 Reasons to Stay Aggressive in 2024

by

By Brian Nelson, CFA 1. The Fed has signaled that rate cuts could start with inflation at a 2 handle (2 point something) and not at exactly 2.0%. That means that the Fed may become anticipatory to prevent overshooting to the downside with inflation. We see this as positive for long-duration equities, particularly those whose free cash flow generation is robust in the out-years, inclusive of big cap tech and the stylistic area of large cap growth. 2. Unemployment is at structural lows of 3.7%. Employers are working hard to keep talent on board, and with each paycheck, employees are pumping more and more money into the stock market via retirement accounts. This tailwind remains a stiff one and will … Read more

There Will Be Volatility

by

By Brian Nelson, CFA Last year, 2022, was a big test for equity investors, and the downside volatility that we witnessed during the year wasn’t comfortable, to say the least. Following the COVID-19 crash and rebound during 2020, and then the market surge in 2021, it wouldn’t be a stretch to say many investors’ heads are probably still spinning from all the volatility witnessed to start this decade. That said, part of what we’ve been warning about the past few years with respect to the equity market, especially in Value Trap, is that the proliferation of price-agnostic trading (e.g. quant, machine/algorithmic trading, etc.) will only lead to more and more market volatility, so while we were somewhat surprised by last … Read more

Johnson & Johnson Belongs in the “Too Hard” Bucket

by

Image Source: Johnson & Johnson By Brian Nelson, CFA Johnson & Johnson (JNJ) recently entered the “too hard” bucket for us. We dropped J&J from the Best Ideas Newsletter portfolio and Dividend Growth Newsletter portfolio on March 13 of the year, as we lost interest in the company given the uncertainties surrounding talc liabilities and the Kenvue (KVUE) split-off. We prefer simplicity across our newsletter portfolios, and J&J’s results have often been messy, to say the least. Though J&J’s second-quarter 2023 performance, released July 20, was a bit better, we no longer have much interest in the name, given its net debt position and contingent talc liabilities. We’re also not interested in shares of its split-off Kenvue, having completely removed … Read more

Markets Bounce Off Technical Support But Not Out of the Woods

by

Image: The market-cap weighted S&P 500 (SPY) bounced off technical support last week, both the 200-day moving average as well as the breakout of the downtrend line, but while this may push off any leg down in the near term, we won’t hesitate to “raise cash” on a few newsletter portfolio names if a breakthrough of support to the downside happens. Image Source: TradingView By Brian Nelson, CFA The 200-day moving average remains a key technical level for the market-cap weighted S&P 500. The risks that the market may break through both the 200-day moving average and the breakout of the technical downtrend line remain elevated, but the past week showed a successful test of technical support levels, in our … Read more

Update: J&J Reports Messy Q4, Free Cash Flow Remains Robust But Looming Kenvue Split Adds Uncertainty

by

Image: Johnson & Johnson’s free cash flow generation remains far in excess of its cash dividends paid. Image Source: J&J By Brian Nelson, CFA Johnson & Johnson (JNJ) reported messy fourth-quarter 2022 results January 24 with GAAP revenue falling 4.4% and reported earnings per share dropping 24.9%. On an adjusted basis, operational growth excluding COVID-19 vaccine sales advanced 4.6%, while adjusted earnings per share advanced 10.3%, to $2.35 per share. The top line missed the consensus estimate modestly, while adjusted earnings per share came in slightly better than expected. Looking ahead to 2023, J&J expects adjusted operational sales growth, excluding COVID-19 vaccine, of 3.5%-4.5%, and adjusted operational earnings per share of $10.40-$10.60, which reflects 3.5% expansion at the midpoint. We … Read more

Dividend Increases/Decreases for the Week of July 21

by

Below we provide a list of firms that raised their dividends during the week ending July 21. The dividend reports of covered firms on this list will be updated shortly with the new information. To access our dividend reports use the ‘Symbol’ search box in our website header. Firms Raising Their Dividends This Week                          Activision Blizzard (ATVI): now $0.99 per share dividend, was $0.47. Aker BP (AKRBY): now $0.162 per share dividend. Banco Macro (BMA): now $0.45 per share quarterly dividend, was $0.0786. Bank of America (BAC): now $0.24 per share quarterly dividend, was $0.22. Bank of America Corporation Deposit Shs Perp Shs Series E (BAC.PE): now $0.3623 per share quarterly dividend, was $0.3222. Bank of New York … Read more

Dividend Increases/Decreases for the Week of July 26

by

Below we provide a list of firms that raised their dividends during the week ending July 26. The dividend reports of covered firms on this list will be updated shortly with the new information. To access our dividend reports use the ‘Symbol’ search box in our website header. Firms Raising Their Dividends This Week                          1st Source (SRCE): now $0.36 per share quarterly dividend, was $0.34. Artisan Partners Asset Management (APAM): now $0.71 per share quarterly dividend, was $0.61. AstraZeneca (AZN): now $1.000 per share interim dividend, was $0.985. Bank of America (BAC): now $0.26 per share quarterly dividend, was $0.24. Bank7 (BSVN): now $0.24 per share quarterly dividend, was $0.21. British American Tobacco (BTI): now 58.88p per share … Read more